Diabetes and Early Development: Epigenetics, Biological Stress, and Aging
American Journal of Perinatology · 01.06.2025 · 42 (08) · 977-987
DOI: 10.1055/a-2405-1493 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Perinatology, erschienen am 01.06.2025. Verfasst von Guanglei Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Pregnancy in Diabetics, Aging, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Common Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Pregestational diabetes, either type 1 or type 2 diabetes, induces structural birth defects including neural tube defects and congenital heart defects in human fetuses. Rodent models of type 1 and type 2 diabetic embryopathy have been established and faithfully mimic human conditions. Hyperglycemia of maternal diabetes triggers oxidative stress in the developing neuroepithelium and the embryonic heart leading to the activation of proapoptotic kinases and excessive cell death. Oxidative stress also activates the unfolded protein response and endoplasmic reticulum stress. Hyperglycemia alters epigenetic landscapes by suppressing histone deacetylation, perturbing microRNA (miRNA) expression, and increasing DNA methylation. At cellular levels, besides the induction of cell apoptosis, hyperglycemia suppresses cell proliferation and induces premature senescence. Stress signaling elicited by maternal diabetes disrupts cellular organelle homeostasis leading to mitochondrial dysfunction, mitochondrial dynamic alteration, and autophagy impairment. Blocking oxidative stress, kinase activation, and cellular senescence ameliorates diabetic embryopathy. Deleting the mir200c gene or restoring mir322 expression abolishes maternal diabetes hyperglycemia-induced senescence and cellular stress, respectively. Both the autophagy activator trehalose and the senomorphic rapamycin can alleviate diabetic embryopathy. Thus, targeting cellular stress, miRNAs, senescence, or restoring autophagy or mitochondrial fusion is a promising approach to prevent poorly controlled maternal diabetes-induced structural birth defects. In this review, we summarize the causal events in diabetic embryopathy and propose preventions for this pathological condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland.
- Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland.
Förderung
- Common Fund
Zitieren
APA
Wang, G., Shen, W. B., Chen, A. W., Reece, E. A., & Yang, P. (2025). Diabetes and Early Development: Epigenetics, Biological Stress, and Aging. American Journal of Perinatology, 42(08), 977-987. https://doi.org/10.1055/a-2405-1493
Vancouver
Wang G, Shen WB, Chen AW, Reece EA, Yang P. Diabetes and Early Development: Epigenetics, Biological Stress, and Aging. American Journal of Perinatology. 2025;42(08):977-987. doi:10.1055/a-2405-1493
BibTeX
@article{Wang2025,
author = {Wang, Guanglei and Shen, Wei-Bin and Chen, Anna Wu and Reece, E Albert and Yang, Peixin},
title = {Diabetes and Early Development: Epigenetics, Biological Stress, and Aging},
journal = {American Journal of Perinatology},
year = {2025},
volume = {42},
number = {08},
pages = {977--987},
doi = {10.1055/a-2405-1493}
}
EUVIMED